Bottom line
BBIN vs QEFA: the short answer
BBIN (JPMorgan BetaBuilders International Equity ETF) and QEFA (State Street(R) SPDR(R) MSCI EAFE StrategicFactors(SM) ETF) share a meaningful slice of their top holdings — about 60% by weight.
BBIN is cheaper at 0.07% vs 0.3% — a difference of $23 a year per $10,000 invested.
Over five years, BBIN returned +9.1% a year vs +8.4% for QEFA.
Updated Nov 19, 2026
BBIN vs QEFA side by side
| BBIN | QEFA | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | J.P. Morgan | SPDR (State Street) |
| Category | International Stock | International Stock |
| Expense ratio | 0.07% | 0.3% |
| Annual cost per $10k | $7 | $30 |
| 10-yr cost on $10k (prospectus) | $90 | $381 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +32.1% | +28.7% |
| 5-yr return (annualized) | +9.1% | +8.4% |
| 10-yr return (annualized) | — | +8.1% |
| Best quarter | +18.3% | +15.7% |
| Worst quarter | −23.1% | −19.6% |
| Net assets (fund) | $6.6B | $1.0B |
| Number of holdings | 643 | 647 |
| Portfolio turnover | 5% | 16% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBIN | QEFA | Difference |
|---|---|---|---|
| 2025 | +32.1% | +28.7% | +3.3% |
| 2024 | +3.5% | +2.7% | +0.8% |
| 2023 | +18.2% | +17.3% | +0.9% |
| 2022 | −14.1% | −14.0% | −0.1% |
| 2021 | +11.4% | +12.4% | −1.0% |
| 2020 | +8.6% | +6.9% | +1.7% |
Source: Fund prospectus bar charts
Holdings overlap
16 of BBIN's top 25 holdings also appear in QEFA's top 25.
| Holding | BBIN | QEFA |
|---|---|---|
| ASML Holding NV | 2.93% | 2.52% |
| HSBC Holdings plc | 1.68% | 0.76% |
| Roche Holding AG | 1.38% | 1.85% |
| Novartis AG | 1.37% | 2.12% |
| AstraZeneca plc | 1.21% | 1.86% |
| Shell plc | 1.17% | 1.08% |
| Nestle SA | 1.14% | 1.70% |
| BHP Group Ltd. | 0.98% | 1.05% |
| Allianz SE | 0.87% | 1.05% |
| Sap Se | 0.86% | 0.85% |
| TotalEnergies SE | 0.85% | 0.80% |
| Schneider Electric SE | 0.83% | 0.75% |
| Rolls-Royce Holdings plc | 0.76% | 0.66% |
| ABB Ltd. | 0.70% | 0.88% |
| Novo Nordisk A/S | 0.69% | 1.00% |
Source: SEC Form N-PORT
BBIN top 10
- ASML Holding NV — 2.93%
- HSBC Holdings plc — 1.68%
- Roche Holding AG — 1.38%
- Novartis AG — 1.37%
- AstraZeneca plc — 1.21%
- Shell plc — 1.17%
- Mitsubishi UFJ Financial Group, Inc. — 1.16%
- Nestle SA — 1.14%
- Siemens AG — 1.07%
- Toyota Motor Corp. — 0.99%
QEFA top 10
- ASML Holding NV — 2.52%
- State Street Global Advisors — 2.49%
- Novartis AG — 2.12%
- AstraZeneca PLC — 1.86%
- Roche Holding AG — 1.85%
- Nestle SA — 1.70%
- Unilever PLC — 1.15%
- Shell PLC — 1.08%
- Zurich Insurance Group AG — 1.05%
- Allianz SE — 1.05%
FAQ
What is the difference between BBIN and QEFA?
Which is cheaper, BBIN or QEFA?
Should I own both BBIN and QEFA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.